Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To investigate the efficacy, tolerability, acceptability, and safety of brexpiprazole as monotherapy or adjunct treatment in the acute- and long-term treatment of major depression.
CITATION STYLE
Ralovska, S., Koychev, I., De Crescenzo, F., Marinov, P., & Cipriani, A. (2021). Brexpiprazole versus placebo or other antidepressive agents for treating depression. Cochrane Database of Systematic Reviews, 2021(2). https://doi.org/10.1002/14651858.CD013866
Mendeley helps you to discover research relevant for your work.